Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer

MLA

Farid Rashidi Mehrabadi, et al. “Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.” Cell Reports Medicine, vol. 1, Apr. 2020, p. 100007. EBSCOhost, https://doi.org/10.1016/j.xcrm.2020.100007.

APA

Farid Rashidi Mehrabadi, Javed Khan, Chul Kim, Haobin Chen, Emerson Padiernos, Nitin Roper, Liqiang Xi, Abhilash Venugopalan, DeeDee K. Smart, Elizabeth Akoth, Stephen M. Hewitt, Sivasish Sindiri, Zofia Piotrowska, Cenk Sahinalp, Aparna H. Kesarwala, Christopher Trindade, Olivia Restifo, Anna-Leigh Brown, Shaojian Gao, … Constance M. Cultraro. (2020). Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer. Cell Reports Medicine, 1, 100007. https://doi.org/10.1016/j.xcrm.2020.100007

Chicago

Farid Rashidi Mehrabadi, Javed Khan, Chul Kim, Haobin Chen, Emerson Padiernos, Nitin Roper, Liqiang Xi, et al. 2020. “Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.” Cell Reports Medicine 1 (April): 100007. doi:10.1016/j.xcrm.2020.100007.